[Occurrence of infectious complications during therapy for acute leukemia].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001424:Bacterial Infections / Q000209:etiology*; D003561:Cytarabine / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D009503:Neutropenia / Q000209:etiology; D011241:Prednisone / Q000009:adverse effects; D013866:Thioguanine / Q000009:adverse effects
D000970:Antineoplastic Agents; D003561:Cytarabine; D013866:Thioguanine; D011241:Prednisone; D003630:Daunorubicin
Problematika výskytu infekcních komplikací v průbĕhu lécby akutní leukemie.